Document is current
Any future updates will be listed below
-
Authors
van der Voort, Gemma
Effern, Maike
Yong, Michelle C. R.
Kiwitz, Lukas
Turiello, Roberta
Leonardelli, Sonia
Ng, Susanna
Corvino, Dillon
Bald, Tobias
Glodde, Nicole
Thurley, Kevin
Hasenauer, Jan
Hölzel, Michael
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft, Germany (EXC 2047—390685813)
Deutsche Forschungsgemeinschaft (EXC 2151—390873048)
Deutsche Forschungsgemeinschaft (EXC 2151—390873048)
Horizon Europe - ERC Consolidator Grant 2023 (101126146)
German Federal Ministry for Re- search, Technology and Space (031L0308A)
University of Bonn through the Center for Mathematical Life Sciences
Schlegel Professorship
Deutsche Krebshilfe (70114292)
- License Information
-
More Information
Article History
Received: 25 February 2026
Accepted: 31 May 2026
First Online: 11 June 2026
Competing interests
: M.H. reports travel expenses, honoraria for webinars, and research support from TME Pharma AG unrelated to this work. M.H. also reports honoraria and clinical advisory board membership from OncoMAGNETx Inc., unrelated to this work. M.H. declares that he is listed as a co-inventor on a patent application PCT/US2024/051200 related to Nectin-4 as a biomarker, which is unrelated to this work, and on a PCT application (RH02A02/P-WO) related to a preclinical test platform for biologics unrelated to this work. J.H. consults for DeepOrigin. The other authors do not have a competing interest.
